| [1] Tateishi K, He J, Taranova O, et al.Generation of insulin-secreting islet-like clusters from human skin fibroblasts.J Biol Chem.2008;283(46):31601-31607.[2] Nelson TJ, Martinez-Fernandez A, Yamada S, et al.Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.Circulation.2009; 120(5): 408-416.[3] Nakahata T, Awaya T, Chang H, et al.Derivation of engraftable myogenic precursors from murine ES/iPS cells and generation of disease-specific iPS cells from patients with Duchenne muscular dystrophy (DMD) and other diseases. Rinsho Shinkeigaku.2010;50(11):889.[4] Wernig M, Zhao JP, Pruszak J, et al.Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease.Proc Natl Acad Sci U S A. 2008;105(15):5856-5861.[5] Nishimura K, Nakagawa T, Ono K, et al.Transplantation of mouse induced pluripotent stem cells into the cochlea. Neuroreport.2009;20(14):1250-1254.[6] Coli? M. The 2012 Nobel Prize Laureates in Physiology or Medicine.Vojnosanit Pregl. 2012;69(11):938-939.[7] GURDON JB.The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles.J Embryol Exp Morphol.1962;10:622-640.[8] Wilmut I, Schnieke AE, McWhir J, et al.Viable offspring derived from fetal and adult mammalian cells.Nature.1997; 385(6619):810-813.[9] Takahashi K, Yamanaka S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.Cell.2006;126(4):663-676.[10] Takahashi K, Tanabe K, Ohnuki M, et al.Induction of pluripotent stem cells from adult human fibroblasts by defined factors.Cell.2007;131(5):861-872.[11] Yu J, Vodyanik MA, Smuga-Otto K, et al.Induced pluripotent stem cell lines derived from human somatic cells.Science. 2007; 318(5858):1917-1920.[12] Nakagawa M, Koyanagi M, Tanabe K, et al.Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.Nat Biotechnol.2008;26(1):101-106.[13] Wernig M, Meissner A, Cassady JP, et al.c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell.2008;2(1):10-12.[14] Hanna J, Wernig M, Markoulaki S, et al.Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.Science.2007;318(5858):1920-1923.[15] Meissner A, Wernig M, Jaenisch R.Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.Nat Biotechnol.2007;25(10):1177-1181. [16] Huangfu D, Maehr R, Guo W, et al.Induction of pluripotent stem cells by defined factors is greatly improved by small- molecule compounds.Nat Biotechnol.2008;26(7):795-797.[17] Huangfu D, Osafune K, Maehr R, et al.Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.Nat Biotechnol.2008;26(11):1269-1275.[18] Zhao Y, Yin X, Qin H, et al.Two supporting factors greatly improve the efficiency of human iPSC generation.Cell Stem Cell.2008;3(5):475-479.[19] Woltjen K, Michael IP, Mohseni P, et al.piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 2009;458(7239):766-770.[20] Kaji K, Norrby K, Paca A, et al.Virus-free induction of pluripotency and subsequent excision of reprogramming factors.Nature.2009;458(7239):771-775.[21] Soldner F, Hockemeyer D, Beard C, et al.Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.Cell.2009;136(5):964-977.[22] Yu J, Hu K, Smuga-Otto K, et al.Human induced pluripotent stem cells free of vector and transgene sequences.Science.2009;324(5928):797-801.[23] Zhao XY, Lv Z, Li W, et al.Production of mice using iPS cells and tetraploid complementation.Nat Protoc.2010; 5(5): 963-971.[24] Kang L, Wang J, Zhang Y, et al.iPS cells can support full-term development of tetraploid blastocyst-complemented embryos.Cell Stem Cell.2009;5(2):135-138.[25] Chen L, Kasai T, Li Y, et al.A model of cancer stem cells derived from mouse induced pluripotent stem cells.PLoS One.2012;7(4):e33544.[26] Kajiwara M, Aoi T, Okita K, et al.Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells.Proc Natl Acad Sci U S A. 2012;109 (31):12538-12543.[27] Chen J, Liu H, Liu J, et al.H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs.Nat Genet.2013;45(1): 34-42.[28] Hikichi T, Matoba R, Ikeda T, et al.Transcription factors interfering with dedifferentiation induce cell type-specific transcriptional profiles.Proc Natl Acad Sci U S A.2013;110(16): 6412-6417.[29] Smith BW, Rozelle SS, Leung A, et al.The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiation.Blood.2013;30(122):376-385.[30] Samuel R, Daheron L, Liao S, et al.Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells. Proc Natl Acad Sci U S A.2013.http://www.pnas.org/content/early/2013/07/16/1310675110.full.pdf+html[31] Tamaoki N, Takahashi K, Tanaka T, et al. Dental pulp cells for induced pluripotent stem cell banking.J Dent Res.2010; 89(8): 773-778.[32] Riggs JW, Barrilleaux BL, Varlakhanova N, et al.Induced pluripotency and oncogenic transformation are related processes.Stem Cells Dev.2013;22(1):37-50.[33] Zhao T, Zhang ZN, Rong Z, et al. Immunogenicity of induced pluripotent stem cells.Nature.2011;474(7350):212-215.[34] Grad I, Hibaoui Y, Jaconi M, et al. NANOG priming before full reprogramming may generate germ cell tumours. Eur Cell Mater.2011;22:258-274.[35] Lin T, Chao C, Saito S, et al.p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression.Nat Cell Biol.2005;7(2):165-171.[36] Li H, Collado M, Villasante A, et al.The Ink4/Arf locus is a barrier for iPS cell reprogramming.Nature.2009;460(7259): 1136-1139.[37] Kawamura T, Suzuki J, Wang YV, et al.Linking the p53 tumour suppressor pathway to somatic cell reprogramming.Nature. 2009; 460(7259):1140-1144.[38] Utikal J, Polo JM, Stadtfeld M, et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells.Nature.2009;460(7259):1145-1148.[39] Marión RM, Strati K, Li H, et al.A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity.Nature.2009;460(7259):1149-1153.[40] Hong H, Takahashi K, Ichisaka T, et al.Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.Nature.2009;460(7259):1132-1135.[41] Lin Y, Cheng Z, Yang Z, et al.DNp73 improves generation efficiency of human induced pluripotent stem cells.BMC Cell Biol.2012;13:9.[42] Kim JB, Zaehres H, Wu G, et al.Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature.2008;454(7204):646-650.[43] Hanna J, Saha K, Pando B, et al.Direct cell reprogramming is a stochastic process amenable to acceleration.Nature.2009; 462(7273):595-601.[44] Banito A, Rashid ST, Acosta JC, et al.Senescence impairs successful reprogramming to pluripotent stem cells.Genes Dev.2009;23(18):2134-2139.[45] Prigione A, Fauler B, Lurz R, et al.The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.Stem Cells.2010;28(4): 721-733.[46] Levine AJ, Oren M.The first 30 years of p53: growing ever more complex.Nat Rev Cancer.2009;9(10):749-758. |
